Felbamate
FDA Approved: * September 13, 2011Pharm Company: * AMNEAL PHARMS
Category: Anticonvulsant
Felbamate (marketed under the brand name Felbatol by MedPointe) is an anticonvulsant[1] used in the treatment of epilepsy. It is used to treat partial seizures[2][3] (with and without generalization) in adults and partial and generalized seizures associated with Lennox–Gastaut syndrome in children. However, an increased risk of potentially fatal aplastic anemia and/or liver failure limit the drug's usage to severe refractory epilepsy. Con... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.1 Discussion